Morningstar

Mercy Halo Blood Test Shows Promise in Early Lung Cancer Detection: New Study Shows Performance Similar to LDCT with Clinical Complementarity

WALTHAM, Mass., Nov. 20, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a groundbreaking study leveraging samples ...

Our Lady of Lourdes using new A.I. technology to better detect lung cancer

The new artificial intelligence-based software and robot-assisted biopsy technology helps providers catch and treat lung ...
Healio

Q&A: FDA grants 510(k) clearance to AI-powered lung nodule management tool

Please provide your email address to receive an email when new articles are posted on . The FDA recently cleared Qure.ai’s qCT LN Quant AI solution for lung nodule management. Early detection, precise ...
Business Wire

Oxford Cancer Analytics Raises USD$11M in Series A Funding to Transform Early Lung Cancer Detection and Enable Curative Treatments

OXFORD, England & TORONTO--(BUSINESS WIRE)--Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it ...